NCT06843148 Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
| NCT ID | NCT06843148 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université de Sherbrooke |
| Condition | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-04 |
| Primary Completion | 2030-03 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Metabolic dysfunction-associated steatotic liver disease (MASLD) (aka non-alcoholic fatty liver disease), commonly occurring in individuals with obesity and type 2 diabetes can lead to liver inflammation/ fibrosis. MASLD results from fat being disproportionately deposited in the liver. The goal of this mechanistic study is to investigate metabolic response in patients aged 50 to 80 years with non-alcoholic fatty liver disease, after niacin (vitamin B3) treatment. The main questions it aims to answer are: * Does Niacin lower the fat deposition in the liver? * Does Niacin raise White Adipose Tissue storage of dietary fatty acids? Researchers will compare Niacin to a placebo (a look-alike substance that contains no drug) to compare the metabolic response. Duration of study per participant: Up to 28 weeks
Eligibility Criteria
Inclusion Criteria: * aged 50 to 80 years; * diagnosed with MASLD, defined as the presence of liver steatosis + abdominal obesity (as defined by the International Diabetes Federation country/ethnic group-specific criteria; * all women will be post-menopausal. Exclusion Criteria: 1. Presence of advanced fibrosis (i.e., ≥ F3 based on liver stiffness \> 10kPa) using vibration-controlled transient elastography (FibroScan), serum ALT \> 3 times the normal upper limit, or signs of portal hypertension \[106-109\]. 2. Other hepatic disease. 3. Previous diagnosis of diabetes. 4. Overt cardiovascular or renal disease, cancer (other than non-melanoma skin cancer), or other uncontrolled medical conditions. 5. Any contraindication to MRI. 6. Previous intolerance or allergy to nicotinic acid. 7. Having participated to a research study with exposure to radiation in the last two years before the start of the study. 8. Being allergic to eggs 9. Smoking (\>1 cigarette/day) and/or consumption of \>2 alco